Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The transmembrane protein 188 pseudogene is a nonfunctional, gene-like segment of DNA in the human genome that resembles the gene for transmembrane protein 188 but does not code for a functional protein product. Like most pseudogenes, it likely arose through gene duplication or mutation events and contains disabling sequence changes (such as frameshifts or premature stop codons). There is no evidence for any direct biological, pharmacological, or disease-related role for this pseudogene, and it does not serve as a drug target or biomarker. The pseudogene designation makes it important only in the context of genome annotation and evolutionary studies—not in therapeutics or clinical applications[2][4]. Key facts: - **Pseudogenes** are prevalent in the human genome; they can sometimes confound genetic study or biomarker design due to sequence similarity with active genes, but do not have product or drug target roles[2][4]. - While rare pseudogenes have been shown to play regulatory or evolutionary roles, there is no evidence that "transmembrane protein 188 pseudogene" has any such function[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane protein 188 pseudogene.